Neuroendocrine responses to d-fenfluramine and insulin-induced hypoglycemia in chronic fatigue syndrome.
Bearn, J, Allain, T, Coskeran, P et al. · Biological psychiatry · 1995 · DOI
Quick Summary
This study tested whether ME/CFS might be caused by problems with the brain's hormone-control system (the pituitary and adrenal glands). Researchers gave patients and healthy people two different tests—one using low blood sugar and another using a serotonin-stimulating drug—to measure hormone responses. They found that ME/CFS patients had unusual patterns in some hormones, suggesting their glands may not be working normally.
Why It Matters
This study provides early evidence that ME/CFS may involve dysfunction in the hypothalamic-pituitary-adrenal (HPA) axis—a central system controlling stress responses and energy metabolism. Understanding these neuroendocrine abnormalities could explain why ME/CFS patients experience such severe fatigue and may eventually lead to more targeted treatments.
Observed Findings
Attenuated prolactin responses to insulin-induced hypoglycemia in CFS patients compared to controls
Elevated peak ACTH concentrations in CFS patients (36.44 ± 4.45 pg/mL) versus controls (25.60 ± 2.78 pg/mL)
Greater overall ACTH response to hypoglycemia in CFS group
Cortisol response patterns that did not significantly differ between groups despite elevated ACTH
Inferred Conclusions
CFS involves dysfunction at both the pituitary level (reduced prolactin secretion) and adrenal cortical level (impaired ACTH-to-cortisol coupling)
HPA axis impairment may be central to ME/CFS pathophysiology rather than reflecting peripheral fatigue
The pattern of results is compatible with impaired adrenal cortical function in ME/CFS
Neurobiological basis of these abnormalities requires further investigation to develop rational treatments
Remaining Questions
What is the underlying neurobiological mechanism causing these pituitary and adrenal abnormalities?
Do these hormonal changes correlate with symptom severity, symptom duration, or functional impairment?
What This Study Does Not Prove
This study does not prove that HPA axis dysfunction causes ME/CFS, only that it is associated with the condition. It does not establish whether these hormonal changes are primary defects or secondary consequences of illness. The findings also cannot be generalized beyond the specific patient population tested, and correlation between test results and clinical symptoms was not established.
Tags
Symptom:Fatigue
Biomarker:Blood Biomarker
Method Flag:Weak Case DefinitionNo ControlsSmall Sample